Inspire Medical Systems, Inc.
INSP
$42.44
$0.160.38%
NYSE
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 1.62% | 12.25% | 10.49% | 10.82% | 22.75% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 1.62% | 12.25% | 10.49% | 10.82% | 22.75% |
| Cost of Revenue | -9.89% | 0.23% | -1.93% | 16.18% | 24.04% |
| Gross Profit | 3.70% | 14.37% | 12.84% | 9.86% | 22.52% |
| SG&A Expenses | 5.48% | 14.45% | 21.84% | 20.77% | 14.86% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 1.43% | 7.28% | 13.76% | 15.52% | 13.15% |
| Operating Income | 24.71% | 44.62% | -32.64% | -165.03% | 90.24% |
| Income Before Tax | -42.37% | 37.35% | -33.33% | -121.50% | 144.46% |
| Income Tax Expenses | 1,073.18% | -6,174.43% | 97.87% | 19.66% | 79.54% |
| Earnings from Continuing Operations | -477.47% | 286.36% | -46.30% | -136.68% | 129.91% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -477.47% | 286.36% | -46.30% | -136.68% | 129.91% |
| EBIT | 24.71% | 44.62% | -32.64% | -165.03% | 90.24% |
| EBITDA | 156.06% | 45.31% | -17.61% | -98.49% | 110.84% |
| EPS Basic | -490.76% | 298.17% | -45.31% | -136.95% | 129.81% |
| Normalized Basic EPS | -40.34% | 30.16% | -11.83% | -84.08% | 144.33% |
| EPS Diluted | -493.50% | 308.36% | -43.57% | -138.03% | 129.41% |
| Normalized Diluted EPS | -39.16% | 32.93% | -10.39% | -83.71% | 143.47% |
| Average Basic Shares Outstanding | -3.37% | -2.97% | -1.83% | -0.75% | 0.29% |
| Average Diluted Shares Outstanding | -5.31% | -4.99% | -3.37% | -2.96% | 2.35% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |